These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36639755)

  • 1. Serotype distribution and antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates among adult and elderly population before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco.
    Nzoyikorera N; Diawara I; Katfy M; Katfy K; Maaloum F; Nyandwi J; Belabbes H; Elmdaghri N; Zerouali K
    BMC Infect Dis; 2023 Jan; 23(1):24. PubMed ID: 36639755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco.
    Diawara I; Barguigua A; Katfy K; Nayme K; Belabbes H; Timinouni M; Zerouali K; Elmdaghri N
    Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):23. PubMed ID: 28376809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive pneumococcal disease among children younger than 5 years of age before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco.
    Diawara I; Zerouali K; Katfy K; Zaki B; Belabbes H; Najib J; Elmdaghri N
    Int J Infect Dis; 2015 Nov; 40():95-101. PubMed ID: 26434380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW.
    Ruiz García Y; Nieto Guevara J; Izurieta P; Vojtek I; Ortega-Barría E; Guzman-Holst A
    Expert Rev Vaccines; 2021 Jan; 20(1):45-57. PubMed ID: 33507135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility and clonality of Streptococcus pneumoniae isolates recovered from invasive disease cases during a period with changes in pneumococcal childhood vaccination, Norway, 2004-2016.
    Siira L; Vestrheim DF; Winje BA; Caugant DA; Steens A
    Vaccine; 2020 Jul; 38(34):5454-5463. PubMed ID: 32616324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotypes and antimicrobial resistance of
    León ME; Samudio M; Kawabata A; Nagai M; Rojas L; Zárate N; Irala J; Leguizamón M; Gómez G; Ortellado J; Blasco R; Franco R; Chamorro G
    J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37289483
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.
    Camilli R; D'Ambrosio F; Del Grosso M; Pimentel de Araujo F; Caporali MG; Del Manso M; Gherardi G; D'Ancona F; Pantosti A;
    Vaccine; 2017 Aug; 35(35 Pt B):4587-4593. PubMed ID: 28716556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.
    dos Santos SR; Passadore LF; Takagi EH; Fujii CM; Yoshioka CR; Gilio AE; Martinez MB
    Vaccine; 2013 Dec; 31(51):6150-4. PubMed ID: 23747454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population genetic structure, serotype distribution and antibiotic resistance of
    Gagetti P; Lo SW; Hawkins PA; Gladstone RA; Regueira M; Faccone D; Sireva-Argentina Group ; Klugman KP; Breiman RF; McGee L; Bentley SD; Corso A
    Microb Genom; 2021 Sep; 7(9):. PubMed ID: 34586054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa.
    Tempia S; Wolter N; Cohen C; Walaza S; von Mollendorf C; Cohen AL; Moyes J; de Gouveia L; Nzenze S; Treurnicht F; Venter M; Groome MJ; Madhi SA; von Gottberg A
    BMC Infect Dis; 2015 Oct; 15():450. PubMed ID: 26496761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan.
    Chi HC; Hsieh YC; Tsai MH; Lee CH; Kuo KC; Huang CT; Huang YC
    J Microbiol Immunol Infect; 2018 Jun; 51(3):332-336. PubMed ID: 28082066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptococcus pneumoniae serotype 19A in hospitalized children with invasive pneumococcal disease after the introduction of conjugated vaccines in Lima, Peru.
    Ochoa TJ; Del Águila O; Reyes I; Chaparro E; Castillo ME; Campos F; Saenz A; Hernandez R; Luna-Muschi A; Castillo-Tokumori F; Montero AE; Gonzales BE; Mercado EH
    J Infect Public Health; 2024 Jan; 17(1):44-50. PubMed ID: 37992433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility and serotype replacement of Streptococcus pneumoniae in children before and after PCV13 introduction in Taiwan.
    Huang H; Lin CY; Chiu NC; Huang DT; Huang CY; Chi H
    J Microbiol Immunol Infect; 2023 Apr; 56(2):299-310. PubMed ID: 36127232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the changing pneumococcal national immunisation program among older Australians.
    Menzies R; Stein AN; Booy R; Van Buynder PG; Litt J; Cripps AW
    Vaccine; 2021 Jan; 39(4):720-728. PubMed ID: 33384189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016.
    Demczuk WHB; Martin I; Desai S; Griffith A; Caron-Poulin L; Lefebvre B; McGeer A; Tyrrell GJ; Zhanel GG; Gubbay J; Hoang L; Levett PN; Van Caeseele P; Raafat Gad R; Haldane D; Zahariadis G; German G; Daley Bernier J; Strudwick L; Mulvey MR
    Vaccine; 2018 Jul; 36(31):4701-4707. PubMed ID: 29937245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptococcus pneumoniae carriage among febrile children at the time of PCV-10 immunization in pediatric emergencies at Mohammed VI University Hospital Centre in Marrakesh (Morocco).
    Dilagui I; Moussair FZ; Loqman S; Diawara I; Zerouali K; Belabbes H; Zouhair S; Bourouss M; Bouskraoui M; Soraa N
    Arch Pediatr; 2019 Nov; 26(8):453-458. PubMed ID: 31645292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of pneumococcal conjugate vaccines on the incidence of invasive pneumococcal disease caused by ten non-vaccine serotypes in Denmark.
    Slotved HC; Dalby T; Hoffmann S
    Vaccine; 2016 Feb; 34(6):769-74. PubMed ID: 26772630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.